FDA Approves Drug To Prevent Migraines


The Food and Drug Administration (FDA) approved a new medication on Thursday designed to prevent migraines.

The drug, called Aimovig, produced by pharmaceutical giants Amgen and Novartis, is intended to be administered through a monthly injection, and would cost patients $6,900 annually, Amgen said.

The drug blocks a protein fragment called CGRP, which is believed to play a critical role in migraines, the company said. Amgen said that it expects to make the drug available to patients in the U.S. within a week.

Read more at The Hill.



  1. stop with the flu shot already. in every article that has anything to do with medicine or illness you are busy with the flu shot. it is not relevant here and unless someone is talking about flu, the flu shot is a ridiculous comparison
    you are so hyper-focused on the flu shot without saying anything l’maaseh
    and if your intent is to make fun of the flu shot – no one is picking up on your sarcasm

Leave a Reply to don't be so shocked. Cancel reply

Please enter your comment!
Please enter your name here